Launched this week
Nucleo
Automated cancer diagnostics
80 followers
Automated cancer diagnostics
80 followers
World models are the hottest race in AI right now. Every frontier lab is building one - but they're all aimed at robotics, generalist agents, autonomous vehicles. None at oncology. We're the first.
Nucleo
Hey PH!
We're building a world model for oncology. AI that can predict and simulate disease progression based on a patient's full history across imaging, treatment, and clinical data.
That's our vision. Today, we're shipping clinical AI tools for medical imaging that serve as the building blocks (for example, automated body-composition analysis, tumor detection and tumor characterization) toward that vision. These are already powering studies in leading US hospitals, and they're how we're generating revenue while we build toward something bigger.
Medical imaging AI today looks at a single scan in isolation. It doesn't account for prior scans, treatment history, or how the disease has evolved. Radiologists carry that longitudinal understanding in their heads, but their software doesn't. We think that's one of the fundamental limitations holding back AI in cancer care.
I'm Luca and my co-founder is Angelica. We started working together in 2023 at Stanford's Department of Medicine. Between that and my time on Apple's Health AI team, we kept seeing world-class research that never reached the tools clinicians actually use. Nucleo exists to close that gap!